Allegro™ STR Single-Use Bioreactor Platform: simplify your process scale-up journey up to 2000L
The Allegro STR Bioreactor family including their specifications, capabilities and applications are intorduced. The Bioreactor system’s key differentiators and advantages with usability aspects are briefly outlined. The process control options, aspects and data are illustrated. The engineering & performance of the technology in terms of oxygen transfer rate and mixing times are provided. The scale up and technology transfer aspects are given followed by several case studies with data demonstrating predictability, reproducibility and reliability. Furthermore, the scientific consultancy and support services offered by Pall are promoted.
Speaker
Shahin Heshmatifar
Bioprocess Application Specialist
Pall Biotech
Shahin Heshmatifar is a Senior Bioreactor Applications Scientist and a member of the Cell Culture Technologies team at Pall Biotech (SLS – IPS - Cell Culture Technologies, EMEA). Has been dedicated to training bioreactor customers and providing scientific consultancy and advice on the transfer of their processes into Pall bioreactor technologies and process optimization. Experienced Biochemical Engineer with a demonstrated history of working in R&D. Knowledgeable and skilled in Upstream and Downstream Process Development, molecular bioanalytics and GMP. Held commercial and sales role in a major global biotechnology company. Worked for a global vaccines manufacturing company as a Bioprocess Development Scientist and Project Lead.
Allegro™ STR Single-Use Bioreactor Platform: simplify your process scale-up journey up to 2000L
Scalable Upstream Process Development of Biotherapeutics
Register to learn more about improvements in current mammalian expression platforms, cell line development and scalability workflows.
Biotech | Pall Corporation webinar series
In 2019 Swissfillon were inspected and approved by the FDA to supply drug products into the USA, following on from EU approval in 2018. This young fill finish CMO was started in Switzerland in 2013 and built a state-of-the-art cGMP production facility from the ground up.
Swissfillon recognized early on that single-use systems met their requirements for multi-product manufacturing and would help their clients get their drugs to market faster.
During this case-study webinar, participants will learn:
- How working in partnership with a supplier can be part of a QbD approach to minimize risk
- Strategies & design improvements for single-use systems to reduce risk in the process
- How a shadowboard can be used to make single-use system leak tests, PUPSIT and the filtration process fast, safe and simple